List of works - Elizabeth R Rayburn

Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD.

scientific article

Antisense approaches in drug discovery and development.

scientific article

Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9

scientific article published on 01 June 2006

Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics

scientific article published on 01 April 2007

Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.

scientific article published on June 2007

Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy

scientific article published on November 2006

Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides

scientific article

Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients.

scientific article

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

scientific article published on 01 August 2006

In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng

scientific article published on 22 August 2006

KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology

scientific article

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy

scientific article

Novel MDM2 p53-independent functions identified through RNA silencing technologies

scientific article

Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action

scientific article

Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling molecules

scientific article

Oncogenes as novel targets for cancer therapy (part III): transcription factors

scientific article

Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis

scientific article

Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.

scientific article published on 2 February 2007

RYBP stabilizes p53 by modulating MDM2

scientific article

Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway

scientific article

Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics

scientific article

Wnt/beta-catenin signaling pathway as a novel cancer drug target

scientific article

List of works by Elizabeth R Rayburn

Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD.

Antisense approaches in drug discovery and development.

Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9

Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics

Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53.

Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy

Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides

Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients.

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng

KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy

Novel MDM2 p53-independent functions identified through RNA silencing technologies

Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action

Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling molecules

Oncogenes as novel targets for cancer therapy (part III): transcription factors

Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis

Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.

RYBP stabilizes p53 by modulating MDM2

Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway

Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics

Wnt/beta-catenin signaling pathway as a novel cancer drug target